2452-302x

JACC Basic to Translational Science

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1686 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1686 DOIs
2

Attach ORCID iDs across 1197 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1197 DOIs
3

Deposit reference lists for 270 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact270 DOIs

DOIs for this ISSN

Showing the top 5 of 1686 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-T… (10.1016/j.jacbts.2020.02.004)
Abstract ORCID
144.72 783
2 Limitations of Animal Studies for Predicting Toxicity in Cli… (10.1016/j.jacbts.2019.10.008)
Abstract ORCID
138.65 592
3 The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atheros… (10.1016/j.jacbts.2018.09.004)
Abstract ORCID
132.07 437
4 Fibroblasts in the Infarcted, Remodeling, and Failing Heart (10.1016/j.jacbts.2019.02.006)
Abstract ORCID
126.45 337
5 Empagliflozin Increases Cardiac Energy Production in Diabete… (10.1016/j.jacbts.2018.07.006)
Abstract ORCID
126.19 333
6 Drugs, Devices, and the FDA: Part 1 (10.1016/j.jacbts.2016.03.002)
Abstract ORCID
122.82 285
7 Radiation-Induced Endothelial Vascular Injury (10.1016/j.jacbts.2018.01.014)
Abstract ORCID
122.82 285
8 CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required… (10.1016/j.jacbts.2017.12.006)
Abstract ORCID
120.41 255
9 COVID-19 for the Cardiologist (10.1016/j.jacbts.2020.04.002)
Abstract ORCID
117.61 224
10 SGLT2 Inhibitor–Induced Sympathoinhibition (10.1016/j.jacbts.2019.11.007)
Abstract ORCID
116.92 217
11 Atrial Myopathy (10.1016/j.jacbts.2019.05.005)
Abstract ORCID
116.42 212
12 Drugs, Devices, and the FDA: Part 2 (10.1016/j.jacbts.2016.03.009)
Abstract ORCID
114.83 197
13 Metabolic Origins of Heart Failure (10.1016/j.jacbts.2016.11.009)
Abstract ORCID
113.82 188
14 Drugs and Devices (10.1016/j.jacbts.2016.06.003)
Abstract ORCID
112.88 180
15 Murine Models of Heart Failure With Preserved Ejection Fract… (10.1016/j.jacbts.2017.07.013)
Abstract ORCID
112.76 179
16 Cardiac Microvascular Endothelial Enhancement of Cardiomyocy… (10.1016/j.jacbts.2019.04.003)
Abstract ORCID
111.39 168
17 Limitations of Animal Studies for Predicting Toxicity in Cli… (10.1016/j.jacbts.2020.03.010)
Abstract ORCID
110.34 160
18 Emerging Applications of Virtual Reality in Cardiovascular M… (10.1016/j.jacbts.2017.11.009)
Abstract ORCID
110.21 159
19 Targeting the Inflammasome in Cardiovascular Disease (10.1016/j.jacbts.2021.08.006)
Abstract ORCID
109.23 152
20 Unilateral Carotid Body Resection in Resistant Hypertension (10.1016/j.jacbts.2016.06.004)
Abstract ORCID
108.80 149
21 JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Patholog… (10.1016/j.jacbts.2019.05.013)
Abstract ORCID
108.80 149
22 Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondr… (10.1016/j.jacbts.2016.06.009)
Abstract ORCID
108.22 145
23 SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarc… (10.1016/j.jacbts.2018.10.002)
Abstract ORCID
107.77 142
24 SARS-CoV-2 Infects Human Engineered Heart Tissues and Models… (10.1016/j.jacbts.2021.01.002)
Abstract ORCID
107.61 141
25 Role of Endothelium in Doxorubicin-Induced Cardiomyopathy (10.1016/j.jacbts.2018.06.005)
Abstract ORCID
107.15 138
26 Empagliflozin Prevents Worsening of Cardiac Function in an E… (10.1016/j.jacbts.2017.07.003)
Abstract ORCID
106.68 135
27 Targeting Vascular Calcification in Chronic Kidney Disease (10.1016/j.jacbts.2020.02.002)
Abstract ORCID
106.36 133
28 Decentralized Clinical Trials (10.1016/j.jacbts.2021.01.011)
Abstract ORCID
105.19 126
29 Endothelial- and Immune Cell-Derived Extracellular Vesicles… (10.1016/j.jacbts.2017.08.004)
Abstract ORCID
105.02 125
30 Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and D… (10.1016/j.jacbts.2020.07.009)
Abstract ORCID
105.02 125
31 Krüppel-Like Factors (10.1016/j.jacbts.2017.09.001)
Abstract ORCID
104.14 120
32 A Novel Biological Strategy for Myocardial Protection by Int… (10.1016/j.jacbts.2019.08.007)
Abstract ORCID
103.78 118
33 Elamipretide Improves Mitochondrial Function in the Failing… (10.1016/j.jacbts.2018.12.005)
Abstract ORCID
103.22 115
34 Galectin-3 Regulates Atrial Fibrillation Remodeling and Pred… (10.1016/j.jacbts.2016.03.003)
Abstract ORCID
103.03 114
35 Ticagrelor Reduces Thromboinflammatory Markers in Patients W… (10.1016/j.jacbts.2018.05.005)
Abstract ORCID
102.85 113
36 Targeting the Mitochondria in Heart Failure (10.1016/j.jacbts.2019.07.009)
Abstract ORCID
102.46 111
37 Phase II Trials in Drug Development and Adaptive Trial Desig… (10.1016/j.jacbts.2019.02.005)
Abstract ORCID
102.27 110
38 Inhibition of Interleukin-17A, But Not Interleukin-17F, Sign… (10.1016/j.jacbts.2016.07.009)
Abstract ORCID
102.07 109
39 Characterization of the Myocardial Inflammatory Response in… (10.1016/j.jacbts.2018.08.006)
Abstract ORCID
101.67 107
40 Epigenetics in Cardiac Hypertrophy and Heart Failure (10.1016/j.jacbts.2019.05.011)
Abstract ORCID
101.67 107
41 Cardiosphere-Derived Cells Reverse Heart Failure With Preser… (10.1016/j.jacbts.2016.01.003)
Abstract ORCID
101.47 106
42 PCSK9 Modulates the Secretion But Not the Cellular Uptake of… (10.1016/j.jacbts.2016.06.006)
Abstract ORCID
101.47 106
43 Fir(e)ing the Rhythm (10.1016/j.jacbts.2022.12.004)
Abstract ORCID
100.85 103
44 Empagliflozin Improves Diastolic Function in a Nondiabetic R… (10.1016/j.jacbts.2018.11.010)
Abstract ORCID
100.22 100
45 Myeloperoxidase Inhibition Improves Ventricular Function and… (10.1016/j.jacbts.2016.09.004)
Abstract ORCID
99.78 98
46 FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy (10.1016/j.jacbts.2016.05.004)
Abstract ORCID
99.11 95
47 Epigenetics in Cardiac Fibrosis (10.1016/j.jacbts.2018.05.003)
Abstract ORCID
99.11 95
48 Intramyocardial Transplantation of Human iPS Cell–Derived Ca… (10.1016/j.jacbts.2020.11.017)
Abstract ORCID
99.11 95
49 Relationship of Nonalcoholic Fatty Liver Disease and Heart F… (10.1016/j.jacbts.2021.07.010)
Abstract ORCID
99.11 95
50 Therapeutic Angiogenesis for Peripheral Artery Disease (10.1016/j.jacbts.2017.07.012)
Abstract ORCID
98.42 92